Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-World Study of Mimeixin for Severe Cancer Pain
NCT06897917Phase 4Not yet recruiting
- Sponsor
- Henan Cancer Hospital
- Start
- Apr 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Mimeixin in cancer pain, opioid-induced constipation (OIC), sponsored by Henan Cancer Hospital. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
Mimeixin
03
Conditions
cancer painopioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT06897917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06897917.